Anthera Pharmaceuticals Reports 2015 First Quarter and Operational Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
Citi Upgrades Anthera Pharma (ANTH) to Neutral
May 12, 2015 7:25 AM EDTCiti upgraded Anthera Pharma (NASDAQ: ANTH) from Sell to Neutral.
For an analyst ratings summary and ratings history on Anthera Pharma click here. For more ratings news on Anthera Pharma click here.
Shares of Anthera Pharma closed at $4.48 yesterday.
... MoreAnthera Pharma (ANTH) Tops Q1 EPS by 3c
May 11, 2015 5:31 PM EDTAnthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.
... More


